252 related articles for article (PubMed ID: 20633035)
1. Inhibitory RNA in epilepsy: research tools and therapeutic perspectives.
Boison D
Epilepsia; 2010 Sep; 51(9):1659-68. PubMed ID: 20633035
[TBL] [Abstract][Full Text] [Related]
2. Adenosine kinase as a target for therapeutic antisense strategies in epilepsy.
Theofilas P; Brar S; Stewart KA; Shen HY; Sandau US; Poulsen D; Boison D
Epilepsia; 2011 Mar; 52(3):589-601. PubMed ID: 21275977
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation.
Boison D; Stewart KA
Biochem Pharmacol; 2009 Dec; 78(12):1428-37. PubMed ID: 19682439
[TBL] [Abstract][Full Text] [Related]
4. Role of Adenosine Kinase Inhibitor in Adenosine Augmentation Therapy for Epilepsy: A Potential Novel Drug for Epilepsy.
Wang X; Li T
Curr Drug Targets; 2020; 21(3):252-257. PubMed ID: 31633474
[TBL] [Abstract][Full Text] [Related]
5. Adenosine dysfunction in epilepsy.
Boison D
Glia; 2012 Aug; 60(8):1234-43. PubMed ID: 22700220
[TBL] [Abstract][Full Text] [Related]
6. Adenosinergic signaling in epilepsy.
Boison D
Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
[TBL] [Abstract][Full Text] [Related]
7. The role of adenosine in epilepsy.
Weltha L; Reemmer J; Boison D
Brain Res Bull; 2019 Sep; 151():46-54. PubMed ID: 30468847
[TBL] [Abstract][Full Text] [Related]
8. Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation.
Fedele DE; Gouder N; Güttinger M; Gabernet L; Scheurer L; Rülicke T; Crestani F; Boison D
Brain; 2005 Oct; 128(Pt 10):2383-95. PubMed ID: 15930047
[TBL] [Abstract][Full Text] [Related]
9. Reactive A1 Astrocyte-Targeted Nucleic Acid Nanoantiepileptic Drug Downregulating Adenosine Kinase to Rescue Endogenous Antiepileptic Pathway.
Zhu J; Qiu W; Wei F; Wang Y; Wang Q; Ma W; Xiong H; Cui Y; Li X; Xu R; Lin Y
ACS Appl Mater Interfaces; 2023 Jun; 15(25):29876-29888. PubMed ID: 37334941
[TBL] [Abstract][Full Text] [Related]
10. Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.
Boison D
Epilepsy Res; 2009 Aug; 85(2-3):131-41. PubMed ID: 19428218
[TBL] [Abstract][Full Text] [Related]
11. The adenosine kinase hypothesis of epileptogenesis.
Boison D
Prog Neurobiol; 2008 Mar; 84(3):249-62. PubMed ID: 18249058
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice.
Li T; Lan JQ; Boison D
Neuron Glia Biol; 2008 May; 4(2):91-9. PubMed ID: 19674507
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control.
Ren G; Li T; Lan JQ; Wilz A; Simon RP; Boison D
Exp Neurol; 2007 Nov; 208(1):26-37. PubMed ID: 17716659
[TBL] [Abstract][Full Text] [Related]
14. Adenosine Dysfunction in Epilepsy and Associated Comorbidities.
Guo M; Li T
Curr Drug Targets; 2022; 23(4):344-357. PubMed ID: 34602036
[TBL] [Abstract][Full Text] [Related]
15. Adenosine kinase gene modified mesenchymal stem cell transplantation retards seizure severity and associated cognitive impairment in a temporal lobe epilepsy rat model.
Zhou Q; Zhang N; Wang M; Zhao Q; Zhu S; Kang H
Epilepsy Res; 2024 Feb; 200():107303. PubMed ID: 38306957
[TBL] [Abstract][Full Text] [Related]
16. Adenosine kinase, epilepsy and stroke: mechanisms and therapies.
Boison D
Trends Pharmacol Sci; 2006 Dec; 27(12):652-8. PubMed ID: 17056128
[TBL] [Abstract][Full Text] [Related]
17. Adenosine kinase: An epigenetic modulator in development and disease.
Murugan M; Fedele D; Millner D; Alharfoush E; Vegunta G; Boison D
Neurochem Int; 2021 Jul; 147():105054. PubMed ID: 33961946
[TBL] [Abstract][Full Text] [Related]
18. Adenosine kinase determines the degree of brain injury after ischemic stroke in mice.
Shen HY; Lusardi TA; Williams-Karnesky RL; Lan JQ; Poulsen DJ; Boison D
J Cereb Blood Flow Metab; 2011 Jul; 31(7):1648-59. PubMed ID: 21427729
[TBL] [Abstract][Full Text] [Related]
19. Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches.
Pagonopoulou O; Efthimiadou A; Asimakopoulos B; Nikolettos NK
Neurosci Res; 2006 Sep; 56(1):14-20. PubMed ID: 16846657
[TBL] [Abstract][Full Text] [Related]
20. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies.
Boison D
Neurodegener Dis; 2007; 4(1):28-33. PubMed ID: 17429216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
